Empaglifozin

empagliflozin

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Empaglifozin, covering 2022-08-02 to 2022-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production [Phase 1]